Changes in allelic imbalances in locally advanced breast cancers after chemotherapy

In advanced breast cancers, TP53 mutation is highly predictive of complete response to high-dose epirubicin/cyclophosphamide chemotherapy. In these tumours with an altered control of genomic stability, accumulation of chemotherapy-induced genetic alterations may contribute to cell death and account...

Descripción completa

Detalles Bibliográficos
Autores principales: Varna, M, Soliman, H, Feugeas, J-P, Turpin, E, Chapelin, D, Legrès, L, Plassa, L-F, de Roquancourt, A, Espié, M, Misset, J-L, Janin, A, de Thé, H, Bertheau, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360433/
https://www.ncbi.nlm.nih.gov/pubmed/17876337
http://dx.doi.org/10.1038/sj.bjc.6603937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360433/
https://www.ncbi.nlm.nih.gov/pubmed/17876337
http://dx.doi.org/10.1038/sj.bjc.6603937

Ejemplares similares